BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7505361)

  • 1. Effects of spiraprilat, an angiotensin-converting enzyme inhibitor, on anesthetized dogs in a new model of acute left ventricular failure.
    Nakazawa M; Ishihara T; Takahashi Y; Okuhira M; Imai S
    J Cardiovasc Pharmacol; 1993 Oct; 22(4):585-93. PubMed ID: 7505361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative hemodynamic effects of MK-422, a converting enzyme inhibitor, and a renin inhibitor in dogs with acute left ventricular failure.
    Sweet CS; Ludden CT; Frederick CM; Bush LR; Ribeiro LG
    J Cardiovasc Pharmacol; 1984; 6(6):1067-75. PubMed ID: 6084762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic effects of angiotensin and renin inhibition in dogs with acute left ventricular failure.
    Sweet CS; Ludden CT; Frederick CM; Ribeiro LG
    Am J Med; 1984 Aug; 77(2A):7-12. PubMed ID: 6089558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined effects of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism in conscious pigs with congestive heart failure.
    Shen YT; Wiedmann RT; Greenland BD; Lynch JJ; Grossman W
    Cardiovasc Res; 1998 Aug; 39(2):413-22. PubMed ID: 9798526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enalapril in experimental hypertension and acute heart failure: comparison with calcium channel blockers.
    Sweet CS; Ludden CT; Adkins E; Seymour AA; Emmert S; Ribeiro LG
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S15-9. PubMed ID: 2422487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of long-term therapy with ACE inhibitors, captopril, enalapril and trandolapril, on myocardial energy metabolism in rats with heart failure following myocardial infarction.
    Sanbe A; Tanonaka K; Kobayasi R; Takeo S
    J Mol Cell Cardiol; 1995 Oct; 27(10):2209-22. PubMed ID: 8576937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic and cardiac effects of spiraprilat in normal and sodium depleted conscious dogs.
    Gérard JL; Pussard E; Berdeaux A; Giudicelli JF
    Fundam Clin Pharmacol; 1990; 4(5):547-58. PubMed ID: 2289746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midazolam's effects on myocardial load and coronary perfusion: reduced regional O2 consumption and lactate production during ischemia in dogs.
    Sidi A; Rush W
    J Cardiothorac Vasc Anesth; 1994 Jun; 8(3):302-9. PubMed ID: 8061264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enalaprilat, a new parenteral angiotensin-converting enzyme inhibitor: rapid changes in systemic and coronary hemodynamics and humoral profile in chronic heart failure.
    De Marco T; Daly PA; Liu M; Kayser S; Parmley WW; Chatterjee K
    J Am Coll Cardiol; 1987 May; 9(5):1131-8. PubMed ID: 3033043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac nitric oxide production due to angiotensin-converting enzyme inhibition decreases beta-adrenergic myocardial contractility in patients with dilated cardiomyopathy.
    Wittstein IS; Kass DA; Pak PH; Maughan WL; Fetics B; Hare JM
    J Am Coll Cardiol; 2001 Aug; 38(2):429-35. PubMed ID: 11499734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute hemodynamic effects of the active metabolite of imidapril, (4S)-3-((2S)-2-[N-((1S)-1-carboxy-3-phenyl-propyl)amino]propionyl)-1- methyl-2-oxoimidazolidine-4-carboxylic acid, and enalaprilat in anesthetized dogs.
    Ikeo T; Yabana H; Kurosawa H; Kaburaki M; Kikkawa K; Narita H; Murata S; Yamaguchi I
    Arzneimittelforschung; 1992 Sep; 42(9):1109-14. PubMed ID: 1332727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dexmedetomidine on systemic and coronary hemodynamics in the anesthetized dog.
    Flacke WE; Flacke JW; Bloor BC; McIntee DF; Sagan M
    J Cardiothorac Vasc Anesth; 1993 Feb; 7(1):41-9. PubMed ID: 8094301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additional effects of endothelin receptor blockade and angiotensin converting enzyme inhibition in rats with chronic heart failure.
    Qiu CB; Qiu CS; Hess P; Clozel JP; Clozel M
    Acta Pharmacol Sin; 2001 Jun; 22(6):541-8. PubMed ID: 11747762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between angiotensin receptor antagonism and converting enzyme inhibition in heart failure. Differential acute effects according to the renin-angiotensin system activation.
    Su J; Barbe F; Houël R; Guyene TT; Crozatier B; Hittinger L
    Basic Res Cardiol; 1999 Apr; 94(2):128-35. PubMed ID: 10326661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased regional lactate production and output due to intracoronary continuous infusion of esmolol during acute coronary occlusion in dogs.
    Sidi A; Rush W
    J Cardiothorac Vasc Anesth; 1991 Jun; 5(3):237-42. PubMed ID: 1677824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic effects of benazeprilat in the anesthetized dog with acute left ventricular failure.
    Nakazawa M; Sawanobori T; Iwasaki K; Imai S
    Jpn J Pharmacol; 1991 Jul; 56(3):369-75. PubMed ID: 1895581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a new angiotensin converting enzyme inhibitor, enalapril, in acute and chronic left ventricular failure in dogs.
    Leddy CL; Wilen M; Franciosa JA
    J Clin Pharmacol; 1983; 23(5-6):189-98. PubMed ID: 6308067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diastolic properties in canine hypertensive left ventricular hypertrophy: effects of angiotensin converting enzyme inhibition and angiotensin II type-1 receptor blockade.
    Hayashida W; Donckier J; Van Mechelen H; Charlier AA; Pouleur H
    Cardiovasc Res; 1997 Jan; 33(1):54-62. PubMed ID: 9059528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal effects of atrial natriuretic factor during control of the renin-angiotensin system in anesthetized dogs.
    Seymour AA; Mazack EK
    Circ Res; 1988 Mar; 62(3):506-14. PubMed ID: 2830044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of dobutamine and corwin, a beta 1-adrenergic partial agonist, in experimental left ventricular failure.
    Vik-Mo H; Yasay G; Maroko PR; Ribeiro LG
    J Cardiovasc Pharmacol; 1985; 7(4):784-90. PubMed ID: 2410722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.